Gunderson Dettmer represented RadioMedix on the deal.RadioMedix announced its $40 million equity financing led by Portland Investment Counsel Inc. RadioMedix is a clinical-stage biotech focused ontargeted radiopharmaceuticals for…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now